MEDICINES CO - NOTE 2.500% 1/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2015 to Q1 2020

Type / Class
Debt / NOTE 2.500% 1/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of MEDICINES CO - NOTE 2.500% 1/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2020 Q1 $0 $0 -$897,032,000 0
2019 Q4 $354,195,000 $897,032,000 +$93,527,775 253.22% 21
2019 Q3 $385,897,500 $584,029,351 +$34,341,666 151.43% 34
2019 Q2 $376,429,000 $456,449,880 +$5,963,725 120.55% 38
2019 Q1 $375,392,000 $376,159,960 -$3,933,931 100.13% 38
2018 Q4 $392,456,000 $338,453,749 -$16,478,616 86.17% 43
2018 Q3 $379,002,000 $407,985,000 +$8,782,993 107.46% 38
2018 Q2 $367,944,000 $447,909,138 -$1,921,589 121.63% 43
2018 Q1 $368,296,290 $426,873,610 +$13,274,630 115.27% 45
2017 Q4 $362,367,290 $385,019,762 -$13,550,542 105.85% 36
2017 Q3 $362,376,000 $458,306,658 -$21,344,827 126.4% 38
2017 Q2 $376,578,000 $517,601,664 -$11,399,808 130.33% 40
2017 Q1 $398,729,012 $629,971,196 +$23,985,748 158.0% 39
2016 Q4 $399,420,009 $480,518,011 -$9,740,723 120.15% 39
2016 Q3 $404,102,000 $524,126,000 +$8,899,502 129.45% 42
2016 Q2 $402,246,000 $476,014,000 +$17,441,922 118.3% 53
2016 Q1 $390,202,000 $442,204,000 +$434,256,083 113.28% 45
2015 Q4 $7,000,000 $8,873,000 +$8,873,000 126.76% 1